Please login to the form below
hematology
This page shows the latest hematology news and features for those working in and with pharma, biotech and healthcare.
ASH 2020: Gilead eyes new Yescarta indication, Vertex/CRISPR make headway in sickle cell and more
A round-up of some of the key data from the annual American Society of Hematology (ASH) meeting. ... It was a bumper year at the annual American Society of Hematology (ASH) meeting, with a slew of new data presented across the board.
Latest news
-
Novartis eyes 2021 regulatory submissions for ‘STAMP’ inhibitor asciminib
CML). The detailed results, presented at the annual American Society of Hematology (ASH) meeting, come from the phase 3 ASCEMBL study.
-
Merck strengthens oncology pipeline with $2.75bn VelosBio deal
Results from a phase 1 clinical trial of the ADC, which are due to be presented at the upcoming virtual American Society of Hematology Annual Meeting, demonstrated that VLS-101 treatment
-
A first for Bluebird and Europe as gene therapy Zynteglo approved
The approval comes just days ahead of a number of important phase 3 read outs for Zynteglo at the European Hematology Association (EHA) congress in Amsterdam.
-
J&J’s targeted bladder cancer treatment gets US approval
with advances being made in new disease types,” said Richard Pazdur, director of the FDA’s Oncology Center of Excellence and acting director of the Office of Hematology and Oncology Products
-
Darzalex powers ahead with frontline myeloma approval in Europe
first investigator to administer daratumumab in human trials and Professor, head of the department of hematology at Vejle Hospital, Denmark.
More from news
Approximately 6 fully matching, plus 52 partially matching documents found.
Latest Intelligence
-
Attracting doctors to low-demand specialties
A brief glance at the programme for the major US haematology congress, held by the American Society of Hematology, tells its own story, with most sessions being dedicated to haematological malignancies
-
Deal Watch November 2016
This does not typically include royalty payments. 2. Ataga et al, Abstract, American Society of Hematology (ASH), December 2016.
-
Deal Watch July 2016
Portfolio of early-stage hematology candidates &option for recombinant pegasparaginase. Licence, option.
More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.
Latest appointments
-
Nanobiotix strengthens US leadership team
Most recently, Dr Obrocea was AbbVie Biotherapeutics' project director and oncology clinical lead, overseeing a number of trials in oncology and hematology.
-
TxCell appoints global scientific advisory board
Prof Chiara Bonini (pictured left) is currently head of the experimental hematology unit at the San Raffaele Scientific Institute, a position she has held since 2008.
More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.
Latest from PMHub
-
Ongoing Virtual Communication between MSLs and Physicians: a Customer Story
Learn how one of our clients used the Impetus InSite Platform to connect their MSLs with regional groups of physicians. In this customer story, we summarize the outcomes from an ongoing project where our client is leveraging a variety of Impetus
-
Highlights in haematologic malignancy from ASH 2018
Earlier this month, Porterhouse Medical attended the 60. th. American Society of Hematology (ASH) Annual Meeting (). The ASH congress is the most comprehensive haematology event of the year, attracting 25, 000
-
Random42 Attending ASH Annual Meeting in San Diego
Now in its 60th year the American Society of Hematology (ASH) annual meeting and exposition is the premier event in malignant and non-malignant hematology. ... The meeting provides an invaluable educational experience and the opportunity to review
-
Increasing the speed of knowledge sharing in blood cancer to improve patient care
Society of Hematology XXXVI World Congress in Congress ( ISH), which was hosted by the British Society for Haematology at the 56th Annual Scientific Meeting, between 18th-21st April.
-
Lighthouse Medical Communications US bolster their senior scientific team
number of key therapeutic areas such endocrinology, neurology, oncology, hematology, women’s health and rare diseases.
More from PMHub
Approximately 3 fully matching, plus 7 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
-
MEDICAL WRITER - HOME WORKING
-
Salary TBC
- Senior Account Director - Med Comms Agency
-
Salary TBC
- Sales Director, Healthcare communications agency, London/ SE UK
-
Six figure salary
- ACCOUNT MANAGER / SENIOR ACCOUNT MANAGER
-
Salary TBC
-
SENIOR MEDICAL WRITER
-
Salary TBC
- Bayer’s finerenone scores FDA priority review for chronic kidney disease
- GSK, Vir halt enrolment of phase 3 COVID-19 antibody study
- UK study finds Pfizer/BioNTech, AZ/Oxford vaccines reduce severe COVID-19 in older people
- AZ sells stake in Moderna for around $1.2bn
- The role of women in science and technology
- Building meaningful customer engagement through data-driven digital insights
- Lilly’s tirzepatide shows superiority over Novo’s semaglutide in type 2 diabetes trial
- Novartis and NHS England reach ‘landmark’ deal for Zolgensma gene therapy for SMA
- EMA recommends use of Lilly’s COVID-19 antibody cocktail
- Merck & Co, Ridgeback Biotherapeutics’ COVID-19 drug shows early promise
- ZENO GROUP HIRES AVRIL LEE AS HEAD OF HEALTHCARE, U.K. AND EUROPE
- Choose to challenge for women’s health on this International Women's Day
PMHub
Healthcare Media Europe – HME Ltd
HME are an innovative and technology enabled agency offering our clients over 35+ years of knowledge and expertise in delivering...
Latest intelligence
- Choose to challenge for women’s health on this International Women's Day
- Today, you could be taking the time to reflect on the inspirational achievements of many women across the world. Or maybe you’re a woman yourself, and you want to take...
- #DemandDiversity: For International Women's Day, we ask... why do women often suffer from more side effects than men?
- Women are largely prescribed exactly the same treatment regimens as men, with no account for the underlying differences in physiology and drug metabolism between the sexes....
- Good design saves lives
- Good design and creative thinking are essential if we are to improve on existing problems in new ways, which is why design and creativity within healthcare is vital. Health is...
Quick links
Infographics
